Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective

Diarmuid Coughlan, Oluwatomi Arisa, Katie Thomson, Ge Yu, Fiona Pearson, Ashleigh Kernohan, Sonia Garcia Gonzalez-Moral, Sheila Wallace, Stephen Rice

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Pages (from-to)5-9
Number of pages5
JournalPharmacoEconomics
Volume42
Issue number1
DOIs
StatePublished - Jan 2024
Externally publishedYes

ASJC Scopus Subject Areas

  • Pharmacology
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this